Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Benjamin Leon Musher"'
Autor:
Benjamin Leon Musher, Brandon George Smaglo, Wasif Abidi, Mohamed Othman, Kalpesh Patel, Salmaan Jawaid, James Jing, Amanda Brisco, Jessica Wenthe, Emma Eriksson, Gustav J. Ullenhag, Linda Sandin, Bambi Grilley, Justyna Leja-Jarblad, Susan G. Hilsenbeck, Malcolm K. Brenner, Eric Keith Rowinsky, Angelica Sara Ingrid Loskog
Publikováno v:
Journal of Clinical Oncology. 40:4138-4138
4138 Background: Due to its low tumor immunogenicity and immunosuppressive microenvironment, pancreatic ductal adenocarcinoma (PDAC) remains an immunotherapeutic challenge. LOAd703, an oncolytic adenovirus with transgenes encoding TMZ-CD40L and 4-1BB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::093c77a30caf8a6f2434cb829d2cbeb6
https://doi.org/10.1200/jco.2022.40.16_suppl.4138
https://doi.org/10.1200/jco.2022.40.16_suppl.4138
Autor:
Arvind Dasari, Maen Abdelrahim, Jared David Acoba, Krishna Chaitanya Alluri, Tomislav Dragovich, Syed Mohammad Ali Kazmi, Benjamin Leon Musher, Ryan Sun, Lucas Wong, Y. Nancy You, Robert Anthony Zaiden, Scott Kopetz
Publikováno v:
Journal of Clinical Oncology. 40:TPS236-TPS236
TPS236 Background: Detection of circulating tumor DNA (ctDNA) in the bloodstream is emerging as a novel marker for identifying of radiographically occult microscopic or minimal residual disease (MRD) in colorectal cancer (CRC) patients (pts) after cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ea6012e42f0a201adc353ced61ae49b
https://doi.org/10.1200/jco.2022.40.4_suppl.tps236
https://doi.org/10.1200/jco.2022.40.4_suppl.tps236
Autor:
Joan Emarine, Sharon Hwang, Benjamin Leon Musher, Melissa L. Ellis, Patti Merwin, Justin A. Barnes, Gregory D. Salinas
Publikováno v:
Journal of Clinical Oncology. 35:431-431
431 Background: Pancreatic ductal adenocarcinoma (PDA) is the fourth-most common cause of cancer-related death in the United States, with only 7.7% of patients surviving beyond 5 years. Given the poor outcomes associated with PDA, it is imperative th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74016055e2d507184ba2e846922c8073
https://doi.org/10.1200/jco.2017.35.4_suppl.431
https://doi.org/10.1200/jco.2017.35.4_suppl.431
Autor:
Benjamin Leon Musher, Brandon G. Smaglo, Henry Mok, Mehmet Akce, Hop S. Tran Cao, Yvonne H. Sada, Nader Nabile Massarweh
Publikováno v:
Journal of Clinical Oncology. 35:148-148
148 Background: Althoughmultimodality therapy (MMT) is recommended for most patients with resectable gastric cancer, no single approach has been established as standard. As such, little is known about current national practice patterns and MMT treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eff6ac4de5654f461b5ad249df446eda
https://doi.org/10.1200/jco.2017.35.4_suppl.148
https://doi.org/10.1200/jco.2017.35.4_suppl.148
Autor:
Henry Mok, Brandon G. Smaglo, Benjamin Leon Musher, Hop S. Tran Cao, Mehmet Akce, Nader Nabile Massarweh, Yvonne H. Sada
Publikováno v:
Journal of Clinical Oncology. 35:107-107
107 Background: Recent data from the MAGIC trial show that pathologically positive lymph nodes (ypN+) despite neoadjuvant (NA) chemotherapy are associated with poorer survival. Although the use of NA therapy has increased, pathologic disease response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51d7dc25d99cfcf97e4cf2e0e0e566df
https://doi.org/10.1200/jco.2017.35.4_suppl.107
https://doi.org/10.1200/jco.2017.35.4_suppl.107